Guangzhou Wondfo Biotech Co.,Ltd

Equities

300482

CNE100002102

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E. 06:00:00 2024-04-24 pm EDT 5-day change 1st Jan Change
26.83 CNY -0.26% Intraday chart for Guangzhou Wondfo Biotech Co.,Ltd +20.86% -11.07%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Guangzhou Wondfo Biotech Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Guangzhou Wondfo Biotech Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Guangzhou Wondfo Biotech Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Tranche Update on Guangzhou Wondfo Biotech Co.,Ltd's Equity Buyback Plan announced on July 5, 2023. CI
Guangzhou Wondfo Biotech Co.,Ltd's Equity Buyback announced on July 5, 2023 has closed with 1,121,900 shares, representing 0.25% for CNY 30.1 million. CI
Guangzhou Wondfo Biotech Co.,Ltd announces an Equity Buyback for CNY 50 million worth of its shares. CI
Guangzhou Wondfo Biotech Co.,Ltd authorizes a Buyback Plan. CI
Beijing PolySeq Technology Co., Ltd. announced that it has received CNY 100 million in funding from Guangzhou Wondfo Biotech Co.,Ltd, Guangzhou Sanmei Investment Management Center (Limited Partnership), Shangshi Capital, IDG Capital Partners Co., Ltd., Tsinghua Innovation Ventures CI
Guangzhou Wondfo Biotech Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Guangzhou Wondfo Biotech Co.,Ltd Approves the Cash Dividend for the Year 2022, Payable on 18 May 2023 CI
Announcement on Resolutions of the 2022 Annual General Meeting of Guangzhou Wondfo Biotech CI
Guangzhou Huiyin Tianyue Nominates Mr.Ge Xinhua as Supervisor CI
Guangzhou Wondfo Biotech Co.,Ltd Proposes Final Cash Dividend for the Year 2022 CI
Guangzhou Wondfo Biotech Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Beijing PolySeq Technology Co., Ltd. announced that it expects to receive CNY 40 million in funding from Guangzhou Wondfo Biotech Co.,Ltd, Guangzhou Sanmei Investment Management Center (Limited Partnership), Shangshi Capital, IDG Capital Partners Co., Ltd., Tsinghua Innovation Ventures CI
Investors bet on greed and fear as China loosens COVID grip RE
Guangzhou Wondfo Biotech Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Tranche Update on Guangzhou Wondfo Biotech Co.,Ltd's Equity Buyback Plan announced on September 26, 2022. CI
Guangzhou Wondfo Biotech Co.,Ltd's Equity Buyback announced on September 26, 2022, has expired with 1,046,200 shares, representing 0.24% for CNY 30.10 million. CI
Guangzhou Wondfo Biotech Co.,Ltd announces an Equity Buyback for CNY 50 million worth of its shares. CI
Guangzhou Wondfo Biotech Co.,Ltd authorizes a Buyback Plan. CI
Guangzhou Wondfo Biotech Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Guangzhou Wondfo Biotech Co.,Ltd announced that it expects to receive CNY 1 billion in funding CI
Guangzhou Wondfo Biotech Co.,Ltd Announces Cash Dividend, Payable on 14 June 2022 CI
Guangzhou Wondfo Biotech Co.,Ltd Approves Cash Dividend for the Year 2021 CI
Chart Guangzhou Wondfo Biotech Co.,Ltd
More charts
GUANGZHOU WONDFO BIOTECH CO., LTD. is a China-based company principally engaged in research, manufacture and sales of point-of-care testing (POCT) reagents, POCT instrument and related products. According to the testing result, the Company' products can be divided into qualitative testing products and quantitative testing products. According to the usage, the Company' products include pregnancy testing series, infectious diseases testing series, drugs (drug abuse) testing series and chronic disease testing series. The Company's products are used in POCT, clinical test, field test and personal health management, among others.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
26.83 CNY
Average target price
31.73 CNY
Spread / Average Target
+18.25%
Consensus
  1. Stock Market
  2. Equities
  3. 300482 Stock
  4. News Guangzhou Wondfo Biotech Co.,Ltd
  5. Guangzhou Wondfo Biotech : Falls Nearly 4% as It Repurchases Shares